Combination Biomarkers for Risk Stratification in Patients with Chronic Heart Failure Biomarkers Prognostication in HF

Heart failure (HF) is a complex clinical syndrome that leads to a malfunctioning cardiac pump, preventing adequate perfusion to internal organs and peripheral tissues1. The prevalence of HF is approximately 6.2 million patients in the United States and 23 million worldwide, with approximately 50% of the cases being HF with reduced ejection fraction (HFrEF). Fortunately, the survival after HF has been improving, but the 5-year mortality is still close to 50%1.

Source: Journal of Cardiac Failure - June 18, 2021 Category: Cardiology Authors: Zekun Feng, Olumuyiwa P. Akinrimisi, Jeffrey A. Gornbein, Quynh A. Truong, Saumya Das, Jagmeet P. Singh, Olujimi Ajijola Source Type: research